Gyl Financial Synergies »

United Therapeutics Corporation shares owned by Gyl Financial Synergies

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Gyl Financial Synergies from 13F filings

Historical chart of Gyl Financial Synergies investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Gyl Financial Synergies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Gyl Financial Synergies

Quarter filed Position value Share count Share price at filing
2024-09-30 $338k 942 358.35
2024-06-30 $330k 1.0k 318.55

More positions owned by Gyl Financial Synergies

Ishares Tr Msci Usa Qlt Fct (QUAL)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Apple (AAPL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Ishares Msci Emrg Chn (EMXC)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Goldman Sachs (GS)
Philip Morris International (PM)
Eli Lilly & Co. (LLY)

View all positions for Gyl Financial Synergies

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Geode Capital Management
FMR
LSV Asset Management
AQR Capital Management
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Pacer Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation